Ignite Creation Date:
2025-12-24 @ 7:19 PM
Ignite Modification Date:
2025-12-26 @ 1:59 AM
Study NCT ID:
NCT02704403
Status:
TERMINATED
Last Update Posted:
2022-03-23
First Post:
2016-02-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Sponsor:
Genfit
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-03
Start Date Type:
None
Primary Completion Date:
2020-10-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-10-28
Completion Date Type:
ACTUAL
First Submit Date:
2016-02-16
First Submit QC Date:
None
Study First Post Date:
2016-03-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-01-07
Results First Submit QC Date:
None
Results First Post Date:
2022-03-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-25
Last Update Post Date:
2022-03-23
Last Update Post Date Type:
ACTUAL